Manual Diaphragmatic Release on Ventilatory Functions in Women With Rheumatoid Arthritis

ConditionsRheumatic Arthritis Lung Function

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age40-60

SponsorMiddle East University

About this trial

Evaluate the effect of manual diaphragmatic release on ventilatory functions in women with rheumatoid arthritis

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All women will have rheumatoid arthritis for more than 2 years with low-to-moderate disease activity.

Normal to mildly restrictive lung pattern.

Their ages will be ranged from 40 to 60 years old.

Their body mass index will be less than 30 Kg/m2.

Disqualifiers

Chronic chest diseases.

Recent parenteral steroid administration.

Cardiovascular disorders (coronary heart disease, heart failure, cardiac arrhythmia, peripheral arterial disease, uncontrolled hypertension).

Smokers.

Trial design

Design model

Parallel

Treatments tested in this trial

Aerobic training
Other intervention
For twelve weeks, the women in the study group will participate in aerobic training on cycle ergometer. Each session will consist of 30-45 minutes of cycling at a moderate intensity, accompanied by a workout heart rate ranging from 65% to 75% of the maximal heart rate and ranging between 12 and 14 on the Borg rating of perceived exertion 20-point scale. After ten minutes of warm-up, every session will end with a brief 3-minute period of cool-down.
Manual Diaphragm Release
Other intervention
The participant will assume a supine position with relaxed limbs. The therapist should position themselves at the head of the participant and make manual contact with the pisiform, hypothenar region, and the last three fingers on both sides, underneath the seventh to tenth rib costal cartilages. The therapist's forearms should be aligned towards the participant's shoulders. During the inspiratory phase, the therapist gently pulled the points of contact with both hands in the direction of the head and slightly laterally, accompanying the elevation of the ribs. Therapist progressively increases the depth of their contact within the costal margin.

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: Manual diaphragmatic release groupActive comparator 2 interventions

Group B: Control groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

Ventilatory function

Ventilatory function parameters, including forced vital capacity and forced expiratory volume in the first second will be measured by experienced technicians at baseline and after 12 weeks in all groups using the Medgraphics pulmonary function testing system (Breezesuite Ultima PFX, Milano, Italy) in strict adherence to the guidelines outlined in the user manual.

Time frame

At baseline and 12 weeks

Secondary outcomes

Functional capacity

Cardiopulmonary exercise test will be conducted for all women at baseline and post-study based on the guidelines set by the American College of Sports Medicine to determine maximal oxygen consumption for each women.

Time frame

At baseline and after 12 weeks

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Middle East University

Lead sponsor

Kasr El Aini Hospital

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: